2025 Annual Meeting | C97 - Challenging Clinical Cases in Pediatric Neurocritical Care: Diagnosis, Management, and Prognostication

Date Monday 04/07/25

Time 07:00 AM - 09:00 AM PDT Add To Calendar

Location San Diego Convention Center | 25A

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Matthew Kirschen, MD, PhD, FAAN

Topic(s) Neuro Trauma and Critical Care

Learning Objectives Participants should become familiar with two scenarios in pediatric neurocritical care that have received significant attention over the last few years: 1) management of cerebral sinovenous thrombosis (CSVT) including the role of anticoagulation and thrombectomy, and 2) the utility of rapid genetic testing in critically ill children with neurological disease.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Recommended Audience Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Audience Participation

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM PDT	Introduction	Challenging Clinical Cases in Pediatric Neurocritical Care: Diagnosis, Management, and Prognostication Matthew Kirschen, MD, PhD, FAAN
07:05 AM - 07:20 AM PDT	Speaker	Diagnostic and Therapeutic Insights into Pediatric CSVT: Imaging, Anticoagulation, and a Brief Focus on Infection-related CSVT Nehali Mehta, MD
07:20 AM - 07:35 AM PDT	Speaker	Beyond Anticoagulation: Exploring Other Strategies in Pediatric CSVT Rachel Vassar, MD
07:35 AM - 07:50 AM PDT	Speaker	Beyond the Vein: Critical Care Management of CSVT Matthew Kirschen, MD, PhD, FAAN
07:50 AM - 08:05 AM PDT	Q&A	Questions and Answers Matthew Kirschen, MD, PhD, FAAN
08:05 AM - 08:20 AM PDT	Speaker	Pro: Rapid Genetic Testing in Critically Ill Children with Acute Brain Injury Eileen Broomall, MD
08:20 AM - 08:35 AM PDT	Speaker	Con: Rapid Genetic Testing in Critically Ill Children with Acute Brain Injury Ingo Helbig, MD
08:35 AM - 08:55 AM PDT	Discussion	Discussion Ingo Helbig, MD
08:55 AM - 09:00 AM PDT	Closing Remarks	Closing Remarks Matthew Kirschen, MD, PhD, FAAN

Faculty Disclosures
Matthew Kirschen, MD, PhD, FAAN	The institution of Dr. Kirschen has received research support from NIH.
Ingo Helbig, MD	The institution of Dr. Helbig has received research support from NIH, German Research Foundation, The Hartwell Foundation, International League Against Epilepsy. Dr. Helbig has received intellectual property interests from a discovery or technology relating to health care.
Nehali Mehta, MD	The institution of Dr. Mehta has received research support from National Insititute of Health.
Rachel Vassar, MD	Dr. Vassar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inozyme.
Eileen Broomall, MD	Dr. Broomall has nothing to disclose.

��ɫ��

��ɫ��